Literature DB >> 19737625

Immuno-biology of Chikungunya and implications for disease intervention.

Yiu-Wing Kam1, Edward K S Ong, Laurent Rénia, Joo-Chuan Tong, Lisa F P Ng.   

Abstract

The re-emergence of Chikungunya fever, an old tropical infectious disease with new characteristics represents a major public health problem with severe social and economic burdens globally. Though Chikungunya has previously been known as a relatively benign disease, its recent re-emergence has caused considerable morbidity with even some cases of fatality. The aggressive waves of the disease are suspected to be due to changes in the virus as well as the vector which makes it appear like a new form of the disease. The study of the human immune response will be crucial in understanding some features of the disease. This review discusses what is currently known on the immuno-biology of Chikungunya and areas that will be important for the development of immune-based antiviral control strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19737625     DOI: 10.1016/j.micinf.2009.09.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  38 in total

1.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection.

Authors:  Fausto Bustos Carrillo; Damaris Collado; Nery Sanchez; Sergio Ojeda; Brenda Lopez Mercado; Raquel Burger-Calderon; Lionel Gresh; Aubree Gordon; Angel Balmaseda; Guillermina Kuan; Eva Harris
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Viperin restricts chikungunya virus replication and pathology.

Authors:  Terk-Shin Teng; Suan-Sin Foo; Diane Simamarta; Fok-Moon Lum; Teck-Hui Teo; Aleksei Lulla; Nicholas K W Yeo; Esther G L Koh; Angela Chow; Yee-Sin Leo; Andres Merits; Keh-Chuang Chin; Lisa F P Ng
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

Review 4.  Chikungunya fever: a threat to global public health.

Authors:  Raíza Nara Cunha Moizéis; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Marcos da Matta Guedes; Hannaly Wana Bezerra Pereira; Daniel Carlos Ferreira Lanza; Judson Welber Veríssimo de Azevedo; Josélio Maria de Araújo Galvão; José Veríssimo Fernandes
Journal:  Pathog Glob Health       Date:  2018-05-28       Impact factor: 2.894

5.  The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.

Authors:  Finny S Varghese; Bastian Thaa; Siti Naqiah Amrun; Diane Simarmata; Kai Rausalu; Tuula A Nyman; Andres Merits; Gerald M McInerney; Lisa F P Ng; Tero Ahola
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

6.  Neutralization activity of patient sera collected during the 2008-2009 Chikungunya outbreak in Thailand.

Authors:  Natsuko Kishishita; Mikiko Sasayama; Naokazu Takeda; Areerat Sa-Ngasang; Atchareeya Anuegoonpipat; Surapee Anantapreecha
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

7.  γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease.

Authors:  Kristin M Long; Martin T Ferris; Alan C Whitmore; Stephanie A Montgomery; Lance R Thurlow; Charles E McGee; Carlos A Rodriguez; Jean K Lim; Mark T Heise
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  HLA class I restriction as a possible driving force for Chikungunya evolution.

Authors:  Joo Chuan Tong; Diane Simarmata; Raymond T P Lin; Laurent Rénia; Lisa F P Ng
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

9.  Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice.

Authors:  Kristin M Long; Alan C Whitmore; Martin T Ferris; Gregory D Sempowski; Charles McGee; Bianca Trollinger; Bronwyn Gunn; Mark T Heise
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.

Authors:  Natsuko Kishishita; Naokazu Takeda; Atchareeya Anuegoonpipat; Surapee Anantapreecha
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.